| Singulair® | |
| Brand Name: | Singulair® |
| Active Ingredient: | montelukast sodium |
| Strength(s): | 4 mg, 5 mg chewable tablets, and 10 mg oral tablets |
| Dosage Form(s): | Oral tablets and chewable tablets |
| Company Name: | Merck Research Laboratories |
| Availability: | Prescription only |
| *Date Approved by the FDA: | February 20, 1998 |
| *Approval by FDA does not mean that the drug is available for consumers at this time. | |
| What is Singulair used for? Singulair is taken to
prevent and treat asthma. The oral tablets are for asthma
patients age 15 years and older, and the chewable tablets are for
pediatric patients 2 years of age and older. Do not take
Singulair to relieve an asthma attack. It is not a replacement for the
quick help that short acting inhalers provide during an asthma attack.
It is very important that you continue taking your other asthma
medicines unless your health care provider tells you to stop.
Who should not take Singulair? Phenylketonuric patients should not take the chewable tablet. The chewable tablet for Singulair contains phenylalanine (a part of aspartame). General Precautions with Singulair?
What should I tell my doctor or health care provider?
What are some possible side effects of Singulair? (This list is NOT a complete list of side effects reported with Singulair. Your health care provider can discuss with you a more complete list of side effects.)
Reports of patients experiences after Singulair
became available include:
For more detailed information about Singulair, ask your health care provider. Link
to Singulair's approved label and patient information
|
|
|
|
Chat Status: |
|
|
